| Jeffrey Michael Hughes, MD | |
|
1100 W Stewart Dr, Orange, CA 92868-3849 | |
| (714) 633-9111 | |
| Not Available |
| Full Name | Jeffrey Michael Hughes |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 1100 W Stewart Dr, Orange, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871525949 | NPI | - | NPPES |
| 00G747980 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | G74798 (California) | Primary |
| Entity Name | Emergency Medicine Specialists Of Orange County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740214733 PECOS PAC ID: 0840185005 Enrollment ID: O20040217000695 |
News Archive
Two million Pakistanis have become ill from malaria, diarrhea, skin diseases or snake bites "since monsoon rains left the southern region under several feet of water, the country's disaster authority said Thursday," Agence France-Presse reports. "More than 350 people have been killed and over eight million people have been affected this year by floods that officials say are worse in parts of Sindh province than last year," the news agency reports.
Agilent Technologies Inc. (NYSE:A) has chosen the Cambridge Health Institute's Next-Generation Sequencing Analysis conference today to introduce its SureSelect Human All Exon Kit for target enrichment prior to next-generation DNA sequencing.
Lotus Pharmaceuticals, Inc.a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China announced today that its wholly owned subsidiary, En Ze Jia Shi Pharmaceuticals, has been issued a patent by the State Intellectual Property Office of the People's Republic of China for controlled-release oral gliclazide. The patent covers the composition and preparation methods for the drug through 2030.
Preliminary results of a pivotal Phase 2 clinical trial of pralatrexate (PDX), a drug that partially works by mimicking folic acid, showed a complete or partial response in 27 percent of patients with recurrent or resistant peripheral T-cell lymphoma (PTCL).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey Michael Hughes, MD Po Box 690, Long Beach, CA 90801-0690 Ph: (562) 809-3547 | Jeffrey Michael Hughes, MD 1100 W Stewart Dr, Orange, CA 92868-3849 Ph: (714) 633-9111 |
News Archive
Two million Pakistanis have become ill from malaria, diarrhea, skin diseases or snake bites "since monsoon rains left the southern region under several feet of water, the country's disaster authority said Thursday," Agence France-Presse reports. "More than 350 people have been killed and over eight million people have been affected this year by floods that officials say are worse in parts of Sindh province than last year," the news agency reports.
Agilent Technologies Inc. (NYSE:A) has chosen the Cambridge Health Institute's Next-Generation Sequencing Analysis conference today to introduce its SureSelect Human All Exon Kit for target enrichment prior to next-generation DNA sequencing.
Lotus Pharmaceuticals, Inc.a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China announced today that its wholly owned subsidiary, En Ze Jia Shi Pharmaceuticals, has been issued a patent by the State Intellectual Property Office of the People's Republic of China for controlled-release oral gliclazide. The patent covers the composition and preparation methods for the drug through 2030.
Preliminary results of a pivotal Phase 2 clinical trial of pralatrexate (PDX), a drug that partially works by mimicking folic acid, showed a complete or partial response in 27 percent of patients with recurrent or resistant peripheral T-cell lymphoma (PTCL).
› Verified 2 days ago
Joseph Villarreal, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 101 The City Dr S, Building 1a, Room 1009, Orange, CA 92868 Phone: 714-456-5239 | |
Scott Rudkin, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: Uci Medical Center, 101 The City Drive South, Orange, CA 92868 Phone: 714-456-2986 | |
Joelle Reynard, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Building 1a, Room 1009, Orange, CA 92868 Phone: 714-456-5239 | |
Dr. Inna Shniter, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 W Stewart Dr, Orange, CA 92868 Phone: 714-771-8113 | |
John C Fox, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: Uci Medical Center, 101 The City Drive South, Orange, CA 92868 Phone: 714-456-2986 | |
Miss Shannon Louise Toohey, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 101 The City Drive South, Bldg 200 , Suite 710, Rt 128-01, Orange, CA 92868 Phone: 715-456-5239 | |
Wirachin Hoonpongsimanont, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-5705 |